HSS Logo Department of Energy Seal
Left Tab SEARCH Right Tab TOOLS Right Tab Left Tab HOME Right Tab Left Tab ABOUT US Right Tab Left Tab FUNCTIONS Right Tab Left Tab RESOURCES Right Tab Left Tab NEWSFEEDS Right Tab Left Tab VIDEOS Right Tab Left Tab EVENTS

Chronic Beryllium Disease Awareness Card and Web Site

Chronic Beryllium Disease Awareness

The U.S Department of Energy's (DOE) Office of Health, Safety and Security (HSS) has launched a new awareness website about Chronic Beryllium Disease (CBD). This website provides a broad-based set of information and resources about beryllium, CBD, CBD symptoms, and consequential conditions of CBD and its treatment. Along with the website, HSS has developed a wallet-sized card for workers and their treating physicians with summary information about CBD and a link to the more detailed CBD awareness website.

The CBD Awareness Card and Web site are part of HSS' corporate outreach initiative to provide information to the worker community, as well as the medical community, and to enhance the likelihood of timely diagnosis and treatment of potential CBD cases.

The primary audience for the CBD Awareness website is:

  • 1. former and current DOE Federal and contractor    workers;
  • 2. practicing clinicians; and
  • 3. healthcare educators and researchers.

The information presented in the CBD Awareness Web site is intended as a general information resource. It is neither intended nor implied to be a substitute for professional medical advice and the care provided by a physician.

Some of the topics covered in the website include:

  • Beryllium, its uses and the work areas and missions where the current or former DOE workforce may have encountered beryllium.
  • Symptoms and clinical findings associated with CBD that may assist a healthcare provider in the diagnosis and treatment of CBD.
  • Medical conditions an individual may develop as a result of CBD or its treatment.
  • Resources available to the current and former DOE workforce that may help facilitate the timely diagnosis of CBD.
  • Links to research about beryllium and CBD that workers, clinicians, doctors and healthcare educators and researchers may find useful.

We hope the information provided will help patients understand the interrelationship between CBD and other medical conditions they may be experiencing. We believe that this information may also help clinicians who may have limited or no experience with CBD to understand the wider affects of the disease.

» Go to the CBD Awareness website.